Bondex Trust

The History

Bondex International, Inc. was founded in 1959 in St. Louis as a small-scale manufacturer specializing in construction-related products. In 1966, Republic Powdered Metals acquired Bondex, expanding its product line.

For nearly two decades, Bondex used asbestos in products such as putties, joint compounds, texture paints, topping cement, and roof cement. As a result, the company became the subject of numerous asbestos-related lawsuits.

By 2010, Bondex International and its parent company, SPHC, filed for bankruptcy due to the financial burden of asbestos litigation. As part of the bankruptcy resolution, the Bondex Trust compensates individuals affected by asbestos exposure from Bondex products.

Purpose of the Trust

The Bondex Trust was created to ensure that asbestos personal injury claims are handled efficiently and fairly. Its primary responsibilities include processing claims, reviewing and approving valid claims, and paying compensation to eligible claimants. The Trust follows the TDP guidelines to ensure equitable treatment across similar claim types.

Why Choose Us for Your Asbestos Exposure Claim?

Free No-Obligation Review

We provide free no-obligation asbestos exposure case review

Contingency Representation

We work on a contingency basis, meaning there are no fees unless we collect for you

Expertise In Asbestos & Mesothelioma Lawsuits

We have experience winning claims against huge multi-national corporations

Eligibility and Claim Process

Claims are processed on a First-In-First-Out (FIFO) basis. Payments are approved through either the Expedited Review (ER) process or the Individual Review (IR) process.

Expedited Review (ER)

This process allows the Trust to review claims quickly. To qualify, applications must meet the presumptive medical and exposure criteria for the applicable disease level.

Individual Review (IR)

Claims that do not meet presumptive criteria undergo an individualized review. This process examines the case in detail and requires additional time due to its complexity.

Compensation and Payment Structure

The Trust evaluates and pays claims on a First-In-First-Out basis. The scheduled values for eligible disease levels are shown below.

Compensation amounts vary based on disease level and the Review process used.

Disease	Scheduled Compensation Value
Mesothelioma (Level VIII)	$80,000
Lung Cancer 1 (Level VII)	$33,333
Lung Cancer 2 (Level VI)	No compensation
Other Cancer (Level V)	$6,667
Severe Asbestosis (Level IV)	$16,667
Asbestosis/Pleural Disease (Level III)	$2,500
Asbestosis/Pleural Disease (Level II)	$800
Other Asbestos Disease (Level I)	$70 (cash discount payment)

Disease

Scheduled Compensation Value

Mesothelioma (Level VIII)

$80,000

Lung Cancer 1 (Level VII)

$33,333

Lung Cancer 2 (Level VI)

No compensation

Other Cancer (Level V)

$6,667

Severe Asbestosis (Level IV)

$16,667

Asbestosis/Pleural Disease (Level III)

$2,500

Asbestosis/Pleural Disease (Level II)

$800

Other Asbestos Disease (Level I)

$70 (cash discount payment)

Conclusion

The Bondex Trust plays an essential role in compensating individuals affected by asbestos exposure from Bondex products. Through a structured claims process, the Trust ensures timely and fair compensation while maintaining consistent treatment for all claimants.